Disclosing Pharmaceutical Company Windfall Profits Act of 2018
Official title: A bill to amend the Securities Exchange Act of 1934 to require additional disclosure for pharmaceutical companies.
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
Disclosing Pharmaceutical Company Windfall Profits Act of 2018
This bill amends the Securities Exchange Act of 1934 to require pharmaceutical companies to make certain public disclosures, including disclosures related to taxation, compensation, dividends, and spending on research and development.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 2885: Disclosing Pharmaceutical Company Windfall Profits Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-S-2885/
"S. 2885: Disclosing Pharmaceutical Company Windfall Profits Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-2885/.
S. 2885, 115th Cong. (2026), https://openamerica.io/bill/115-S-2885/.
[S. 2885: Disclosing Pharmaceutical Company Windfall Profits Act of 2018](https://openamerica.io/bill/115-S-2885/)